Results 151 to 160 of about 283,224 (387)

Core-Shell Magnetic Nanocarriers: Fe3O4-Hydroxyapatite/Polysuccinimide Hybrids for Enhanced Oral Bioavailability of Fluorouracil

International Journal of Nanomedicine
Wenhui Zhang,1 Qiang Wang,2 Fengguo Zhai,1 Xingjun Fan,3 Fanqin Meng,1 Guangzhi Shen,1 Ying Zhu,1 Jingdan Cao,1 Fengbo Yu1 1School of Pharmacy, Mudanjiang Medical University, Mudanjiang, 157011, People’s Republic of China; 2Hongqi People Hospital ...
Zhang W, Wang Q, Zhai F, Fan X, Meng F, Shen G, Zhu Y, Cao J, Yu F   +8 more
doaj  

Decay of Normal and 5-Fluorouracil-Substituted Messenger Ribonucleic Acid of Alkaline Phosphatase in Escherichia coli [PDF]

, 1969
Ezra Yagil, Nava Silberstein
openalex   +1 more source

Mechanisms of base selection by the E.coli mispaired uracil glycosylase [PDF]

, 2008
The repair of the multitude of single-base lesions formed daily in the cells of all living organisms is accomplished primarily by the base-excision repair (BER) pathway that initiates repair through a series of lesion-selective glycosylases.
Darwanto, Agus, Goddard, William, III, Liu, Pingfang, Pascal, Tod, Sowers, Lawrence C., Theruvathu, Jacob A., Valinluck Lao, Victoria   +6 more
core   +2 more sources

Impact of Low Preoperative Prognostic Immune Nutritional Index on Survival and Postoperative Infectious Complications in Patients With Colorectal Cancer

Annals of Gastroenterological Surgery, EarlyView.
ABSTRACT Aim The prognostic immune nutritional index (PINI) is increasingly recognized for its potential clinical utility. However, multifaceted evaluations of its ability to predict oncological outcomes in colorectal cancer (CRC) and its association with postoperative infectious complications remain limited.
Shinji Yamashita, Yoshinaga Okugawa, Hiroki Imaoka, Tadanobu Shimura, Takahito Kitajima, Mikio Kawamura, Yoshiki Okita, Masaki Ohi, Minako Kobayashi, Yuji Toiyama   +9 more
wiley   +1 more source

Partial Satisfaction of a Uracil Requirement by 5-Fluorouracil [PDF]

, 1965
Fred Goodman
openalex   +1 more source

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

New England Journal of Medicine, 2004
T. André, C. Boni, L. Mounedji-Boudiaf, M. Navarro, J. Tabernero, T. Hickish, C. Topham, M. Zaninelli, P. Clingan, J. Bridgewater, I. Tabah-Fisch, A. de Gramont   +11 more
semanticscholar   +1 more source

Conversion Therapy for cT4b and M1 Esophageal Squamous Cell Carcinoma: A Comprehensive Systematic Review

Annals of Gastroenterological Surgery, EarlyView.
We systematically reviewed conversion therapy for esophageal squamous cell carcinoma and propose a response‐based treatment strategy for cT4b and M1 disease. For cT4b, we emphasize definitive chemoradiotherapy with timed re‐evaluation and selective salvage or chemoselection to surgery; for M1, conversion is reserved for limited‐burden responders with ...
Eisuke Booka, Hiroya Takeuchi
wiley   +1 more source

Postirradiation Cell Division in 5-Fluorouracil-pretreated Escherichia coli [PDF]

, 1967
R. Ben‐Ishai, N. Zeevi
openalex   +1 more source

Magnetic Soft Robots for Targeted Bacterial Delivery and Enhanced Tumor Spheroid Disaggregation

Advanced Intelligent Systems, EarlyView.
Magnetic soft robots encapsulating probiotic bacteria offer a new strategy for targeted cancer therapy. These millimeter‐scale hydrogel robots enable magnetically guided delivery, controlled bacterial release, and enhanced tumor spheroid disintegration.
Tamara Krauss, Oncay Yasa, Vitaly Pustovalov, Miriam Filippi, Salvador Pané, Robert Kevin Katzschmann   +5 more
wiley   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source